Ing Groep Nv Danaher Corp Transaction History

Ing Groep Nv

$16.5 Billion
Q3 2024

A detailed history of Ing Groep Nv transactions in Danaher Corp stock. As of the latest transaction made, Ing Groep Nv holds 85,964 shares of DHR stock, worth $19.9 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

85,964

Previous 142,780 39.79%

Holding current value

$19.9 Million

Previous $35.7 Million 33.01%

% of portfolio

0.14%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$239.25 - $280.76 $13.6 Million - $16 Million	-56,816 Reduced 39.79%	85,964 $23.9 Million
Q2 2024 Aug 13, 2024	BUY	$235.51 - $267.98 $14.8 Million - $16.8 Million	62,663 Added 78.21%	142,780 $35.7 Million
Q1 2024 May 10, 2024	SELL	$224.58 - $256.19 $10.5 Million - $12 Million	-46,816 Reduced 36.88%	80,117 $20 Million
Q4 2023 Feb 08, 2024	BUY	$185.1 - $233.13 $4.71 Million - $5.93 Million	25,436 Added 25.06%	126,933 $29.4 Million
Q3 2023 Oct 27, 2023	SELL	$233.08 - $265.59 $7.54 Million - $8.6 Million	-32,370 Reduced 24.18%	101,497 $25.2 Million
Q2 2023 Aug 07, 2023	SELL	$224.99 - $256.14 $1.13 Million - $1.28 Million	-5,010 Reduced 3.61%	133,867 $32.1 Million
Q1 2023 May 09, 2023	SELL	$239.75 - $277.0 $41.9 Million - $48.4 Million	-174,817 Reduced 55.73%	138,877 $35 Million
Q4 2022 Feb 10, 2023	BUY	$241.42 - $282.29 $26.8 Million - $31.4 Million	111,082 Added 54.82%	313,694 $83.3 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $20 Million - $122 Million	80,842 Added 66.39%	202,612 $52.3 Million
Q2 2022 Aug 08, 2022	SELL	$237.11 - $299.66 $8.82 Million - $11.1 Million	-37,190 Reduced 23.4%	121,770 $30.9 Million
Q1 2022 May 13, 2022	BUY	$257.27 - $315.76 $19.5 Million - $24 Million	75,954 Added 91.5%	158,960 $46.6 Million
Q4 2021 Feb 11, 2022	SELL	$292.08 - $329.01 $1.92 Million - $2.16 Million	-6,557 Reduced 7.32%	83,006 $27.3 Million
Q3 2021 Nov 02, 2021	BUY	$272.21 - $332.43 $9.86 Million - $12 Million	36,204 Added 67.85%	89,563 $27.3 Million
Q2 2021 Aug 13, 2021	BUY	$225.08 - $271.69 $1.98 Million - $2.39 Million	8,792 Added 19.73%	53,359 $14.3 Million
Q1 2021 May 12, 2021	SELL	$212.38 - $245.9 $747,152 - $865,076	-3,518 Reduced 7.32%	44,567 $10 Million
Q4 2020 Feb 11, 2021	BUY	$212.5 - $245.46 $5.71 Million - $6.59 Million	26,863 Added 126.58%	48,085 $10.7 Million
Q3 2020 Nov 12, 2020	BUY	$177.16 - $215.33 $1.53 Million - $1.86 Million	8,651 Added 68.82%	21,222 $4.57 Million
Q2 2020 Aug 13, 2020	SELL	$128.7 - $176.83 $820,719 - $1.13 Million	-6,377 Reduced 33.66%	12,571 $2.22 Million
Q1 2020 May 06, 2020	SELL	$121.39 - $169.05 $3.28 Million - $4.56 Million	-26,980 Reduced 58.74%	18,948 $2.62 Million
Q4 2019 Feb 10, 2020	SELL	$133.47 - $153.48 $740,224 - $851,200	-5,546 Reduced 10.77%	45,928 $7.05 Million
Q3 2019 Nov 08, 2019	SELL	$135.4 - $146.47 $6.88 Million - $7.45 Million	-50,832 Reduced 49.69%	51,474 $7.43 Million
Q2 2019 Aug 12, 2019	BUY	$124.88 - $143.73 $11.5 Million - $13.2 Million	91,850 Added 878.44%	102,306 $14.6 Million
Q1 2019 May 13, 2019	SELL	$97.62 - $132.29 $6.28 Million - $8.51 Million	-64,350 Reduced 86.02%	10,456 $1.38 Million
Q4 2018 Feb 13, 2019	BUY	$94.85 - $109.54 $1.64 Million - $1.9 Million	17,313 Added 30.11%	74,806 $7.71 Million
Q3 2018 Nov 06, 2018	SELL	$98.13 - $108.9 $1.68 Million - $1.87 Million	-17,167 Reduced 22.99%	57,493 $6.25 Million
Q2 2018 Aug 10, 2018	BUY	$96.1 - $103.24 $110,034 - $118,209	1,145 Added 1.56%	74,660 $7.37 Million
Q1 2018 May 07, 2018	BUY	$92.16 - $103.8 $598,763 - $674,388	6,497 Added 9.69%	73,515 $7.2 Million
Q4 2017 Feb 06, 2018	SELL	$85.26 - $94.62 $299,688 - $332,589	-3,515 Reduced 4.98%	67,018 $6.22 Million
Q3 2017 Nov 08, 2017	BUY	$79.29 - $88.45 $5.59 Million - $6.24 Million	70,533	70,533 $6.05 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

540M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account